Feasibility of extended dosing intervals of denosumab
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155217703791
Abstract: Purpose Denosumab is a crucial supportive care agent for patients with advanced cancers affecting the bone. Despite the importance of treatment, logistical and financial obstacles hinder the ability to maintain long-term adherence. This analysis was… read more here.
Keywords: feasibility extended; dosing intervals; denosumab; interval group ... See more keywords